Drug companies avert landmark opioids trial as talks on $48 billion settlement set to resume

Credit: Reuters India- Published on October 21, 2019
Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial over their role in the U.S. opioid epidemic.

You are here

Recent related videos from verified sources

Here's the Difference Between Cyber Monday and Alibaba Singles Day 01:16
Credit: The Street - Published 1 week ago 


Melania booed at youth opioid awareness event in Baltimore 01:36
Credit: Reuters Studio - Published 1 week ago 


Behind the Beat: What Drove Burlington's Strong Earnings and Guidance 01:03
Credit: The Street - Published 1 week ago 


EBay sells StubHub for $4.05 billion 00:27
Credit: Rumble - Published 2 weeks ago 


EBay Sells StubHub For $4.05 Billion 00:27
Credit: Wochit - Published 2 weeks ago 


Charles Schwab to Reportedly Purchase TD Ameritrade 01:11
Credit: Wibbitz Top Stories - Published 2 weeks ago 


WEB EXTRA: Opioid Payment App 00:57
Credit: CBS4 Miami - Published 2 weeks ago 


How Investors Should Approach Macy's, Impeachment Hearings, Charles Schwab 04:46
Credit: The Street - Published 2 weeks ago 


Opioid Use May Negatively Impact Sleep 00:34
Credit: Wochit - Published 2 weeks ago 


Bristol-Myers Squibb Has a Skin Cancer Trial Setback 01:38
Credit: The Street - Published 2 weeks ago 


You might like